Samsung gets FDA clearance in US for sleep apnea detection on Galaxy Watch

Samsung has announced that the sleep apnea feature on the Samsung Health Monitor app has received De Novo authorization from the US Food and Drug Administration (FDA). This feature detects the signs of sleep apnea by monitoring blood oxygen levels of the user during sleep through supported Galaxy Watches. The feature will be available in the US through the Samsung Health Monitor app in the third quarter of 2024.

Last year, Samsung received the approval by South Korea’s Ministry of Food and Drug Safety (MFDS) for the same feature.